Discover more insights into 68ga Psma 11 Pet

Keywords frequently search together with 68ga Psma 11 Pet

Narrow sentence examples with built-in keyword filters


Regularized reconstruction of digital time-of-flight 68Ga-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients



Therapeutic efficacy, Prognostic variables and Clinical Outcome of 177Lu-PSMA-617 PRLT in Progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason Score in such cohort.


More 68ga Psma 11 Pet sentence examples
10.1016/j.urology.2018.09.038

Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.


More 68ga Psma 11 Pet sentence examples
10.1016/J.EUO.2018.11.002

Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.


More 68ga Psma 11 Pet sentence examples
10.2967/jnumed.119.231605

Automated synthesis module and sterile cold kit for 68Ga-PSMA-11 do not show differences in PET/CT image quality.


More 68ga Psma 11 Pet sentence examples
10.1097/01.JU.0000555566.85589.6e

PD17-06 MAPPING OF SITE-SPECIFIC RELAPSE IN PATIENTS WITH BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY ASSESSED BY 68GA-PSMA-11 OR 11C-CHOLINE PET/CT: IMPACT OF POSTOPERATIVE ANDROGEN DEPRIVATION THERAPY AND RADIOTHERAPY


More 68ga Psma 11 Pet sentence examples
10.1007/s00345-019-02846-z

68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study


More 68ga Psma 11 Pet sentence examples
10.1016/J.REMN.2018.09.006

Valoración de factores predictivos de positividad en PET con 68Ga-PSMA-11 en el cáncer de próstata



PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography.


More 68ga Psma 11 Pet sentence examples
10.1097/01.JU.0000555139.43594.a9

MP09-15 68GA-PSMA-11 PET/CT IN RECURRENT PROSTATE CANCER: EFFICACY IN DIFFERENT CLINICAL STAGES OF PSA FAILURE


More 68ga Psma 11 Pet sentence examples
10.3760/CMA.J.ISSN.2095-2848.2019.02.002

Value of semi-quantitative indices of 68Ga-PSMA-11 PET/CT in differential diagnosis of malignant and benign prostate lesions


More 68ga Psma 11 Pet sentence examples
10.1038/s41585-019-0181-7

68Ga-PSMA-11 PET enables accurate detection of recurrent disease


More 68ga Psma 11 Pet sentence examples
10.1016/J.REMNIE.2018.07.004

Efficacy of early imaging with 68Ga-PSMA-I&T in the discrimination of pelvic lesions in prostate cancer patients.


More 68ga Psma 11 Pet sentence examples
10.1007/s00259-019-04583-2

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up


More 68ga Psma 11 Pet sentence examples
10.3760/CMA.J.ISSN.2095-2848.2019.02.005

Safety and efficacy of 177Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer


More 68ga Psma 11 Pet sentence examples
10.1186/s13550-019-0538-1

Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer


More 68ga Psma 11 Pet sentence examples
10.1001/jamaoncol.2019.0096

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.


More 68ga Psma 11 Pet sentence examples
10.2967/jnumed.118.219501

Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology


More 68ga Psma 11 Pet sentence examples
10.1200/JCO.2019.37.7_SUPPL.15

Prospective head-to-head comparison of 18F-fluciclovine and 68Ga-PSMA-11 PET/CT for localization of prostate cancer biochemical recurrence after primary prostatectomy.


More 68ga Psma 11 Pet sentence examples
10.1007/s00259-019-04511-4

68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer


More 68ga Psma 11 Pet sentence examples
10.1097/01.JU.0000555567.62718.82

PD17-07 DETECTION RATE OF 68GA-PSMA-11 PET/MRI IN PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY AND LOW PSA VALUES ⩽ 0.5 NG/ML


More 68ga Psma 11 Pet sentence examples
10.2967/jnumed.119.226449

Effect of External Cooling on 177Lu-PSMA Uptake by the Parotid Glands


More 68ga Psma 11 Pet sentence examples
10.2967/jnumed.118.219352

Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes


More 68ga Psma 11 Pet sentence examples
10.1007/s00259-019-04606-y

Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT


More 68ga Psma 11 Pet sentence examples
10.1038/s41571-019-0210-8

68Ga-PSMA-11 PET enables accurate detection of recurrent disease


Learn more from 68ga Psma 11 Pet


68ga Psma 11 Pet
Encyclopedia